Skip to main content
GutCited
Figure 1. Inflammatory bowel diseases (IBD), activation of the nuclear factor-kB (NF-kB), and the possible roles of phytochemicals against this pathway activation during these diseases. ↑, increase; TLRs, Toll-like receptors; IKKα, IkappaB kinase alfa; IKK
Figure 6. Figure 1. Inflammatory bowel diseases (IBD), activation of the nuclear factor-kB (NF-kB), and the possible roles of phytochemicals against this pathway activation during these diseases. ↑, increase; TLRs, Toll-like receptors; IKKα, IkappaB kinase alfa; IKKβ, IkappaB kinase beta; IKB, inhibitor of nuclear factor-kB.

الوصف

Inflammatory bowel diseases are associated with activation of the NF-kB signaling pathway. This diagram illustrates how various phytochemicals may counteract NF-kB pathway activation through inhibition of Toll-like receptors, IKK complex, and downstream transcriptional targets in IBD.

Cite This Figure

![Figure 6: Inflammatory bowel diseases are associated with activation of the NF-kB signaling pathway. This diagram illustrates how various phytochemicals may counteract NF-kB pathway activation through inhibition of Toll-like receptors, IKK complex, and downstream transcriptional targets in IBD.](https://pdfs.citedhealth.com/figures/36677021/176.png)

> Source: Lucas Fornari Laurindo et al. "Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overvi." *Metabolites*, 2023. PMID: [36677021](https://pubmed.ncbi.nlm.nih.gov/36677021/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/36677021/176.png" alt="Inflammatory bowel diseases are associated with activation of the NF-kB signaling pathway. This diagram illustrates how various phytochemicals may counteract NF-kB pathway activation through inhibition of Toll-like receptors, IKK complex, and downstream transcriptional targets in IBD." />
  <figcaption>Figure 6. Inflammatory bowel diseases are associated with activation of the NF-kB signaling pathway. This diagram illustrates how various phytochemicals may counteract NF-kB pathway activation through inhibition of Toll-like receptors, IKK complex, and downstream transcriptional targets in IBD.<br>  Source: Lucas Fornari Laurindo et al. "Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overvi." <em>Metabolites</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36677021/">36677021</a></figcaption>
</figure>